<?xml version="1.0" encoding="UTF-8"?>
<p>Influenza virus strains A/PR/8/34(H1N1; PR8); A/Canada/RV733/2003(H1N1; RV733), an A/New Caledonia/20/1999-like clinical isolate, the 2009 H1N1 pandemic A/Mexico/INDRE4487/2009 (H1N1; pdm09) strain, A/Indonesia/05/2005 (H5N1), and A/Anhui/1/2013 (H7N9) were amplified, concentrated by ultracentrifugation, and titered in MDCK cells by a standard plaque assay or TCID
 <sub>50</sub> procedures [
 <xref rid="B13-viruses-11-01028" ref-type="bibr">13</xref>,
 <xref rid="B21-viruses-11-01028" ref-type="bibr">21</xref>]. All manipulations of live H5N1 and H7N9 viruses were performed in a Respiratory BSL-3 facility, using all Public Health Agency of Canada (PHAC) guidelines and SOPs.
</p>
